Search
Innovative Drug Concept Rallies, Thalys Pharmaceutical's Stock Jumps 20% Daily Limit
3 week ago /
Read about 0 minute
Author：小编
The innovative drug sector witnessed a robust performance in the morning trading session, with Thalys Pharmaceutical's stock reaching the daily limit, accompanied by significant gains in numerous other stocks. The National Medical Products Administration (NMPA) has announced plans to streamline the approval process for clinical trials of innovative drugs, aiming to cut the review time for eligible applications from 60 working days down to 30 working days.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
